For: | Makary MS, Ramsell S, Miller E, Beal EW, Dowell JD. Hepatocellular carcinoma locoregional therapies: Outcomes and future horizons. World J Gastroenterol 2021; 27(43): 7462-7479 [PMID: 34887643 DOI: 10.3748/wjg.v27.i43.7462] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v27/i43/7462.htm |
Number | Citing Articles |
1 |
Nojan Bajestani, Gavin Wu, Ahmed Hussein, Mina S. Makary. Examining the Efficacy and Safety of Combined Locoregional Therapy and Immunotherapy in Treating Hepatocellular Carcinoma. Biomedicines 2024; 12(7): 1432 doi: 10.3390/biomedicines12071432
|
2 |
Guorong Jia, Tao Wang, Rou Li, Xiao Li, Gaofeng Sun, Wei Chen, Ye Peng, Chao Cheng, Jijin Yang, Changjing Zuo. Radioiodine‐131‐Labeled Theranostic Nanoparticles for Transarterial Radioembolization and Chemoembolization Combination Therapy of VX2 Liver Tumor. Advanced Healthcare Materials 2023; 12(32) doi: 10.1002/adhm.202301559
|
3 |
Cody R Criss, Mina S Makary. Salvage locoregional therapies for recurrent hepatocellular carcinoma. World Journal of Gastroenterology 2023; 29(3): 413-424 doi: 10.3748/wjg.v29.i3.413
|
4 |
Ronald S. Arellano. Complications Associated with Image-Guided Percutaneous Thermal Ablation of Liver Tumors. Digestive Disease Interventions 2023; 7(03): 180 doi: 10.1055/s-0042-1760372
|
5 |
John Domini, Mina S. Makary. Single-center analysis of percutaneous ablation in the treatment of hepatocellular carcinoma: long-term outcomes of a 7-year experience. Abdominal Radiology 2023; doi: 10.1007/s00261-023-03819-y
|
6 |
Yanjun Gao, Yingge Li, Zheming Liu, Yi Dong, Siqi Yang, Bin Wu, Mengxia Xiao, Chen Chen, Yingmei Wen, Lei Chen, Haijuan Jiang, Yi Yao. AHSA1 Regulates Hepatocellular Carcinoma Progression via the TGF-β/Akt-Cyclin D1/CDK6 Pathway. Journal of Hepatocellular Carcinoma 2023; : 2021 doi: 10.2147/JHC.S407680
|
7 |
Wen-jun Pei, Hao Zhou, Ying Zeng, Qi-lin Ji, Jing-jing Zhang, Xiu Wang. 3-Bromopyruvate modified with cholesterol enhances anti-hepatoma activity by inducing ferroptosis and apoptosis. Journal of Drug Delivery Science and Technology 2025; 103: 106426 doi: 10.1016/j.jddst.2024.106426
|
8 |
Lauren Matevish, Madhukar S. Patel, Parsia A. Vagefi. Downstaging Techniques for Hepatocellular Carcinoma in Candidates Awaiting Liver Transplantation. Surgical Clinics of North America 2024; 104(1): 145 doi: 10.1016/j.suc.2023.07.004
|
9 |
Suyog Shaha, Danika Rodrigues, Samir Mitragotri. Locoregional drug delivery for cancer therapy: Preclinical progress and clinical translation. Journal of Controlled Release 2024; 367: 737 doi: 10.1016/j.jconrel.2024.01.072
|
10 |
Piaoyi Chen, Qinglin Xiao, Zhaoxiong Guo, Wei Liang, Ou Liu, Liteng Lin, Yugang Huang, Kangshun Zhu, Guodong Ye. Synthesis and characterization of 3-in-1 multifunctional lipiodol-doped Fe3O4@Poly (diallyl isophthalate) microspheres for arterial embolization, chemotherapy, and imaging. Biomedical Materials 2024; 19(3): 035011 doi: 10.1088/1748-605X/ad2c1a
|
11 |
Luca Grisetti, Clarissa J. C. Garcia, Anna A. Saponaro, Claudio Tiribelli, Devis Pascut. The role of Aurora kinase A in hepatocellular carcinoma: Unveiling the intriguing functions of a key but still underexplored factor in liver cancer. Cell Proliferation 2024; 57(8) doi: 10.1111/cpr.13641
|
12 |
Leonardo Gomes da Fonseca, Raphael L C Araujo. Combination approaches in hepatocellular carcinoma: How systemic treatment can benefit candidates to locoregional modalities. World Journal of Gastroenterology 2022; 28(28): 3573-3585 doi: 10.3748/wjg.v28.i28.3573
|
13 |
Nadine Abi-Jaoudeh, Ben Sadeghi, Hanna Javan, Jim Na, Graham Beaton, Fabio Tucci, Satheesh Ravula, David K. Imagawa. Drug-Eluting Embolic Loaded with Tyrosine Kinase Inhibitor Targeted Therapies for Transarterial Chemoembolization in a VX2 Model. Cancers 2023; 15(12): 3236 doi: 10.3390/cancers15123236
|
14 |
Maria Stella Franzè, Paul Vigneron, Anna Sessa, Carlo Saitta, Julia Chalaye, Vania Tacher, Alain Luciani, Hélène Regnault, Ancuta Bejan, Rami Rhaiem, Daniele Sommacale, Vincent Leroy, Raffaele Brustia, Giovanni Raimondo, Giuliana Amaddeo. Prognostic factors influencing outcomes in hepatocellular carcinoma patients undergoing selective internal radiation therapy. Annals of Hepatology 2025; 30(1): 101539 doi: 10.1016/j.aohep.2024.101539
|
15 |
Andrei M. Jipa, Mina S. Makary. Locoregional Therapies for Hepatobiliary Tumors: Contemporary Strategies and Novel Applications. Cancers 2024; 16(7): 1271 doi: 10.3390/cancers16071271
|
16 |
Gavin Wu, Nojan Bajestani, Nooruddin Pracha, Cindy Chen, Mina S. Makary. Hepatocellular Carcinoma Surveillance Strategies: Major Guidelines and Screening Advances. Cancers 2024; 16(23): 3933 doi: 10.3390/cancers16233933
|
17 |
Warren A. Campbell, Jeffrey F. B. Chick, David S. Shin, Mina S. Makary. Value of interventional radiology and their contributions to modern medical systems. Frontiers in Radiology 2024; 4 doi: 10.3389/fradi.2024.1403761
|
18 |
Valli De Re, Anna Rossetto, Alessandro Rosignoli, Elena Muraro, Vito Racanelli, Maria Lina Tornesello, Aron Zompicchiatti, Alessandro Uzzau. Hepatocellular Carcinoma Intrinsic Cell Death Regulates Immune Response and Prognosis. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.897703
|
19 |
Maryam Farzaneh, Majid Ghasemian, Farhoodeh Ghaedrahmati, Jafar Poodineh, Sajad Najafi, Tariq Masoodi, Dedy Kurniawan, Shahab Uddin, Shirin Azizidoost. Functional roles of lncRNA-TUG1 in hepatocellular carcinoma. Life Sciences 2022; 308: 120974 doi: 10.1016/j.lfs.2022.120974
|
20 |
Stephen Susman, Breanna Santoso, Mina S. Makary. Locoregional Therapies for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease. Biomedicines 2024; 12(10): 2226 doi: 10.3390/biomedicines12102226
|
21 |
Long-Bin Jeng, Wen-Ling Chan, Chiao-Fang Teng. Prognostic Significance of Serum Albumin Level and Albumin-Based Mono- and Combination Biomarkers in Patients with Hepatocellular Carcinoma. Cancers 2023; 15(4): 1005 doi: 10.3390/cancers15041005
|
22 |
Elliott L. Fite, Mina S. Makary. Transarterial Chemoembolization Treatment Paradigms for Hepatocellular Carcinoma. Cancers 2024; 16(13): 2430 doi: 10.3390/cancers16132430
|
23 |
Pan Liu, Xu Zhang, Qiang Fu, ChuanJiang Liu, QianKun Luo, PengFei Yu, Song Chen, HongWei Zhang, Tao Qin, Yuanwei Zhang. LINC01419 Promotes the Proliferation of Hepatoma Cells by Recruiting XRCC5 and Regulating Its Phosphorylation to Repair DNA Damage. Disease Markers 2022; 2022: 1 doi: 10.1155/2022/9313680
|
24 |
Kassem Sharif, Adi Lahat, Idan Levy, Shomron Ben Horin. Gastric Perforation After Microwave Ablation to Adjacent Hepatocellular Lesion. ACG Case Reports Journal 2023; 10(6): e01082 doi: 10.14309/crj.0000000000001082
|
25 |
Xiangxiang Lei, Xiaoge Hu, Qiliang Lu, Yingmin Yao, Wen Sun, Qiancheng Ma, Dongsheng Huang, Qiuran Xu. UBE2K promotes the malignant progression of hepatocellular carcinoma by regulating c-Myc. Biochemical and Biophysical Research Communications 2023; 638: 210 doi: 10.1016/j.bbrc.2022.11.046
|
26 |
Warren A. Campbell, Mina S. Makary. Advances in Image-Guided Ablation Therapies for Solid Tumors. Cancers 2024; 16(14): 2560 doi: 10.3390/cancers16142560
|
27 |
Mina S. Makary, Jonathan Alexander, Luis E. Regalado, Sajid Jalil, Khalid Mumtaz, Jincheng Wang. Clinical outcomes of DEB-TACE in locally advanced hepatocellular carcinoma: A 5-year real world experience. PLOS ONE 2024; 19(9): e0309693 doi: 10.1371/journal.pone.0309693
|
28 |
Chen Guo, Randy Donelson, Zhengyu Wang, Amanda Billups, Tongjia Liu, Emma Torii, Danielle Burroughs, Marcus Flowers, Asheesh Shukla, Ryan Jeo, Davis Seelig, Chun Wang, Jafar Golzarian. Whey Protein-Based Hydrogel Microspheres for Endovascular Embolization. ACS Applied Bio Materials 2025; doi: 10.1021/acsabm.4c00473
|
29 |
Attila Kovács, Peter Bischoff, Hathal Haddad, Willi Zhou, Susanne Temming, Andreas Schäfer, Hannah Spallek, Lucas Kaupe, György Kovács, Michael Pinkawa. Long-Term Comparative Study on the Local Tumour Control of Different Ablation Technologies in Primary and Secondary Liver Malignancies. Journal of Personalized Medicine 2022; 12(3): 430 doi: 10.3390/jpm12030430
|
30 |
Roberto Iezzi, Alessandro Posa, Andrea Contegiacomo, In Joon Lee, Reto Bale, Alessandro Tanzilli, Lorenzo Tenore, Felice Giuliante, Antonio Gasbarrini, Shraga Nahum Goldberg, Tobias Jakobs, Maurizio Pompili, Irene Bargellini, Evis Sala, Hyo-Cheol Kim. Early-Stage HCC Percutaneous Locoregional Management: East versus West Perspectives. Cancers 2023; 15(15): 3988 doi: 10.3390/cancers15153988
|
31 |
Yuming Shi, Erfan Taherifard, Ali Saeed, Anwaar Saeed. MASLD-Related HCC: A Comprehensive Review of the Trends, Pathophysiology, Tumor Microenvironment, Surveillance, and Treatment Options. Current Issues in Molecular Biology 2024; 46(6): 5965 doi: 10.3390/cimb46060356
|
32 |
Xiaoying Xu, Yu Liu, Yanyan Liu, Yahan Yu, Mingqi Yang, Ligong Lu, Leung Chan, Bing Liu. Functional hydrogels for hepatocellular carcinoma: therapy, imaging, and in vitro model. Journal of Nanobiotechnology 2024; 22(1) doi: 10.1186/s12951-024-02547-9
|
33 |
Marine Soret, Jacques-Antoine Maisonobe, Philippe Maksud, Stéphane Payen, Manon Allaire, Eric Savier, Charles Roux, Charlotte Lussey-Lepoutre, Aurélie Kas. Feasibility of Liver Transplantation after 90Y Radioembolization: Lessons from a Radiation Protection Incident. Health Physics 2024; 127(3): 373 doi: 10.1097/HP.0000000000001814
|
34 |
Kelly Hao, Andrew J Paik, Lauren H Han, Mina S Makary. Yttrium-90 radioembolization treatment strategies for management of hepatocellular carcinoma. World Journal of Radiology 2024; 16(10): 512-527 doi: 10.4329/wjr.v16.i10.512
|
35 |
Sarah B. White, Dilip Rajasekhar Maddirela. Hepatobiliary Cancers: An Interdisciplinary Approach. Interdisciplinary Cancer Research 2023; 3: 255 doi: 10.1007/16833_2022_122
|
36 |
Josua A. Decker, Christian Scheurig-Muenkler, Jan H. Luitjens, Thomas Kroencke. Nationwide Trends and the Influence of Age and Gender in the In-Patient Care of Patients with Hepatocellular Carcinoma in Germany between 2010 and 2020. Cancers 2023; 15(10): 2792 doi: 10.3390/cancers15102792
|
37 |
Yitong Li, Ruihang Zhang, Zhen Xu, Zhicheng Wang. Advances in Nanoliposomes for the Diagnosis and Treatment of Liver Cancer. International Journal of Nanomedicine 2022; : 909 doi: 10.2147/IJN.S349426
|